Susceptibility trends of Pseudomonas species from corneal ulcers

Indian Journal of Medical Microbiology

Volumn 23, Issue 3, 2005, Pages 168-171

  Smitha, S ^a   Lalitha, P ^a   Prajna, V N ^a   Srinivasan, M ^a  

^a ARAVIND EYE HOSPITAL   (India)

Author keywords

Aminoglycosides; Antimicrobial susceptibilty; Corneal ulcer; Fluoroquinolones; Pseudomonas

Indexed keywords

AMIKACIN; CIPROFLOXACIN; GENTAMICIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TOBRAMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATION; CONTROLLED STUDY; CORNEA ULCER; DIFFUSION; HUMAN; IN VITRO STUDY; KERATITIS; LIQUID CULTURE; NONHUMAN; PSEUDOMONAS; SENSITIVITY AND SPECIFICITY; SOLID STATE; STATISTICAL SIGNIFICANCE;

EID: 23944517744     PISSN: 02550857     EISSN: 02550857     Source Type: Journal    
DOI: 10.4103/0255-0857.16588     Document Type: Article

References (24)

1. Alexandrakis G, Alfonso EC, Miller D. Shifting trends in bacterial keratitis in South Florida and emerging resistance to fluoroquinolones. Ophthalmology 2000; 107 :1497-502.
2. Maria Regina Chalita, Ana Luisa Hofling-Lima, Augusto Paranhos, Pulo Schor, Rubens Belfort. Shifting Trends in Invitro Antibiotic Susceptibilities for common ocular isolates during a period of 15 years. Am J Ophthalmol. 2004; 137 :43-51.
3. Kunimoto DY, Sharma S, Garg P, Rao GN. Invitro susceptibility of bacterial keratitis pathogens to ciprofloxacin. Emerging Resistance. Ophthalmology 1999; 106 :80-5.
4. Goldstein MH, Kowalski RP, Gordon YJ. Emerging fluoroquinolone resistance in bacterial keratitis. Ophthalmology 1999; 106 :1313-8.
5. Garg P, Sharma S, Rao GN. Ciprofloxacin resistant Pseudomonas Keratitis. Ophthalmology 1999; 106 :1319-423.
6. Jensen HG, Felix C. Invitro susceptibilities of ocular isolates in North and South America. Cornea 1998; 17 :79-87.
7. Regis P.Kowalski, Lisa M.Karenchak, Eric G.Romanowski. Infectious disease: changing antibiotic susceptibility. Ophthalmol Clin N Am 2003; 16 :1-9.
8. Srinivasan M, Gonzales CA, Celine George, Vicky Cevallos, Mascarenhas JM, Asokan B, et al. Epideomology and aetiological diagnosis of corneal ulceration in Madurai, South India. British Journal of Ophthalmology 1997; 81 :965-71.
9. Srikanth K, Kalavathy CM, Thomas PA, Jesudasan CAN. Susceptibility of common ocular bacterial pathogens to antibacterial agents. Journal of TNOA 1998; 39 :49-50.
10. Sharma S, Kunimoto DY, Garg P, Rao GN. Trends in antibiotic resistance of corneal pathogens: Part I. An analysis of commonly used ocular antibiotics. Ind J Ophthalmol 1999; 47 :95-100.
11. National Committee for Clinical Laboratory Standards. Performance Standards for antimicrobial disk susceptibility test. The National Committee for Clinical Laboratory Standards.M7-A5, 2000;20.
12. Leibowitz HM. Clinical evaluation of ciprofloxacin 0.3% ophthalmic solution for treatment of bacterial keratitis. Am J Ophthalmol.1991; 112 :34-47.
13. Wilhelmus KR, Hyndiuk RA, Caldwell DR et al. 0.3% of ophthalmic ointment in the treatment of bacterial keratitis. Arch Ophthalmol. 1993; 111 :1210-8.
14. O'Brien TP, Maguire MG, Fink NE et al. Efficacy of Ofloxacin vs cefazolin and tobramycin in therapy for bacterial keratitis. Arch Ophthalmol 1995; 113 :1257-65.
15. Knauf HP, Silvany R, Southern PM, Risser RC, Wilson SE. Susceptibility of corneal and conjunctival pathogens to ciprofloxacin. Cornea 1996; 15 :66-71.
16. Serdarevic ON. Role of fluoroquinolones in Ophthalmology. Int Ophthalmol Clin 1993; 33 :163-78.
17. Synder ME, Katz HR. Ciprofloxacin-resistant bacterial keratitis. Am J Ophthalmol 1992; 114 :336-8.
18. Maffett M, O'Day DM. Ciprofloxacin-resistant bacterial keratitis [letter]. Am J Ophthalmol 1993; 115 :545-6.
19. Sharma S, Kunimoto DY, Rao NT, Prashant Garg, Rao GN. Trends in antibiotic resistance of corneal pathogens: Part II. An analysis of healing bacterial keratitis isolates. Ind J Ophthalmol 1999; 47 :101-9.
20. Brown SF, Bloomfield SE, Tam WI. The cornea destroying enzyme of Pseudomonas aeruginosa. Invest Ophthalmol 1974; 13 :174-80.
21. Bharathi JM, Ramakrishnan R, Vasu S, Meenakshi R, Palaniappan R. Invitro efficacy of antibacterial against bacterial isolates from corneal ulcers. Ind J Ophthalmol 2002; 50 :109-14.
22. Bower KS, Kowalski RP, Gordon YJ. Fluoroquinolones in the treatment of bacterial keratitis. Am J Ophthalmol 1996; 121 :712-5.
23. Chaudhry NA, Flynn HW, Murray TG, Tabandeh H, Mello MO, Miller D. Emerging ciprofloxacin-resistant Pseudomonas aeruginosa. Am J Ophthalmol 1999; 128 :509-10.
24. Blandino G, Marchese A, Ardito F, Fadda G, Fontana R, Lo Cascio G, et al Antimicrobial susceptibility profiles of Pseudomonas aeruginosa and Staphylococcus aureus isolated in Italy from patients with hospital acquired infections. Int J Antimicrob Agents. 2004; 24 :515-8.